Alto Neuroscience Inc (ANRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 14,951 | 18,682 | 15,676 | 16,997 | 18,886 |
| Operating Income | -14,951 | -18,682 | -15,676 | -16,997 | -18,886 |
| Interest Expense | 650 | 646 | 598 | 333 | 349 |
| Other Income | 1,420 | 1,622 | 1,105 | 2,129 | 2,452 |
| Pre-tax Income | -14,181 | -17,706 | -15,169 | -15,201 | -16,783 |
| Net Income Continuous | -14,181 | -17,706 | -15,169 | -15,201 | -16,783 |
| Net Income | $-14,181 | $-17,706 | $-15,169 | $-15,201 | $-16,783 |
| EPS Basic Total Ops | -0.52 | -0.65 | -0.56 | -0.52 | -0.62 |
| EPS Basic Continuous Ops | -0.52 | -0.65 | -0.56 | -0.52 | -0.62 |
| EPS Diluted Total Ops | -0.52 | -0.65 | -0.56 | -0.52 | -0.62 |
| EPS Diluted Continuous Ops | -0.52 | -0.65 | -0.56 | -0.52 | -0.62 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.65 | -0.53 | -0.56 | -0.62 |
| EBITDA(a) | $-14,787 | $-18,513 | $-15,505 | $-16,827 | $-18,764 |